chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 1 hour of vaccine broke out in full body rash and urticaria. Painful, itchy, red and inflamed. Migraine set in 4 hours later. Nausea, vomiting, and severe diarrhea started next day and continued for 5 days. Feverish, fatigue and body ache still persist.
Like I have a bad sun burn; Nerve damage; This case was reported by a consumer via interactive digital media and described the occurrence of burning sensation in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In October 2020, the patient received Shingles vaccine. In October 2021, less than 2 years after receiving Shingles vaccine, the patient experienced burning sensation and nerve damage. On an unknown date, the outcome of the burning sensation and nerve damage were unknown.   It was unknown if the reporter considered the burning sensation and nerve damage to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient received the Shingles shots felt like have a bad sun burn on the front right of chest.  No marks just nerve damage.  The patient was just wondering if anyone had noticed this when having had the vaccine. No contact details were available.
Weakness in back muscles, pins and needles across arms and chest, difficulty breathing, increase in anxiety, sinuses and neck and head have extreme pressure at times.
Information has been received from a registered nurse (R.N.) concerning the nurse with a history of chickenpox who vaccinated approximately 300 people with ZOSTAVAX (Merck) in the last 7 months. Subsequently, the patient experienced constant headaches in the back of his neck. The patient was seeing a neurologist. No product quality complaint was involved. Additional information has been requested.
This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications information was not reported. The reporter stated that because their facility has not been able to download the digital data logger, they have been put on hold by the State at the moment and cannot administer the Moderna COVID-19 vaccine to patients until an assessment by the State was made. There had been no power outages that would have impacted the Moderna vaccine. However, she reiterates that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion.  Reporter stated that no adverse reactions were reported by any patients.
Patient reports feeling dizzy, lightheaded and felt like she was going to pass out. EMS assessed patient, BP: 122/69, pulse: 70,  patient reports feeling better, symptoms improved, she was cleared by EMS.
Pt c/o lightheaded when arriving to observation area, water obtained and WC, transported to med eval area and lying in supine positions.  VS 140/80 ,102P, Resp. 22, 97% sat.  C/o of SOB initial arrival, lungs clear with auscultation.  Drank 16oz water and sitting up with no further c/o of dizziness or SOB.  Sat's 100% and HR down to 88-90's.  Ambulated in area for further evaluation and stable with no further c/o's.  Reviewed with pt for 2nd vaccine to hydrate and get her second shot in the med eval. lying down.  Pt verbalized understanding and discharged ambulatory.
Red rash that covered the front of my upper arm from elbow to shouldar. Arm swelled to nearly twice normal size. Low grade fever for 2 days. Redness and swelling lasted 7 days. Feeling exhausted. Heart tachycardia up to 139 bpm.  Had the same reaction to the first shot on 6/3/2021. Saw MD for the reaction to first shot but not to this second one as it was the same. Used cold compress and rest and fluids for 1 week.
Sick with flu anyway; Initial information received on 16-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health Care professional   This case involves an unknown age and unknown gender patient who was sick with flu anyway after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It is unknown if the patient experienced any additional symptoms/events   It is unknown if the patient had any medical history, concomitant disease or risk factor.   Concomitant medications included COVID-19 VACCINE and PNEUMOCOCCAL VACCINE for Prophylactic vaccination.  On an unknown date, the patient received a suspect Influenza vaccine (strength, dose, formulation, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination   On an unknown date the patient developed a non-serious event sick with flu anyway (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if there were lab data/results available.   Action taken : Not applicable.  It was not reported if the patient received a corrective treatment for the event (Sick with flu anyway).  At time of reporting, the outcome was Unknown for the event sick with flu anyway.
Vaccine Thurs. am, mild stuffiness Sat. Monday student attended classes. Developed severe headache from base skull to front head around eyes, associated with severe dizziness, weakness, severe nausea, left arm cold, numb, with moderate left arm pain from the elbow down. Patient went to ER at around midnight. She was given IV fluids, compazine, Benadryl & sent back to her dormitory @ 04:30 Tues the 23rd. She saw an MD at the health office Wed. afternoon & received Motrin. Her headache remained on & off & she was unable to return to classes. Her dizziness, nausea, weakness, & confusion remained. Thursday the 25th, I, (pt's mother & RN ), came to see her but before I arrived, she called crying asking what was wrong with her. She said she could not walk, was extremely dizzy, nauseated, & had fallen & was "crunching." She was taken via ambulance to Hospital. She was given IV fluids, compazine, which she had been prescribed at the first ER on Mon/Tues. She had only taken 2 oral doses that day for nausea. I arrived 3pm Thurs. She started having what they called "dystonic" movements. She appeared to be having seizure like movements. The staff gave her Benadryl IV. A cpl hrs later the episode occurred again & they repeated Benadryl. They released her 1:30 Fri we had to return less than an hour because she had 2 seizure like episodes in her room. They admitted her to ED for short time just watched her. Only saw neurologist once & routine bloodwork. No CT, no LP, no CT. I brought her home & as of now she still has severe stomach pain, weakness, stiffness, glossy eyes, is "clammy" feeling, states she feels confused/foggy. We are returning to the ED now. Our PCP since the start & his PA has felt this is a severe reaction to the vaccine with the symptoms including the hemipelegia & all the other symptoms & the timing & length of symptoms.
FELT HORRIBLE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced felt horrible. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of felt horrible was not reported. This report was non-serious.
Reports nausea and dizziness about 8:13 am post vaccination. Sat on bench just outside vaccine station. Medical staff summoned and patient taken by wheelchair to Triage 1 and monitored by on site EMTs. Initially with low blood pressure but improved quickly from initial BP of 72/27, then 99/50. Last BP was taken standing at 107/72. Heart rate was initially then 48, then 78 and 82 in that order. Patient's color went from pale to pink and she reported that nausea and dizziness resolved over the course of  15 minutes, continued to monitor for another 15 minutes with improvement and resolution of symptoms continuing. She was released to her significant other who agreed to insure she reached her next destination safely.
Patient woke up with arm soreness and a swollen hand.  He states that hand is swollen difficult to close.  Right hand, same arm as Afluria administered previous day.
Oral lichenoid reaction, very painful. I do not have HSV1 in the mouth, does not look like herpetic lesions. Pending doctor appointment.
On 03/13/2018 this patient expired with SIDS. This report is being generated because do not know if vaccines were a contributing factor. There was smoking around child, and child had been sleeping with mother at checkup visit.
developed a rash after 2nd dose; This case was reported by a consumer via call center representative and described the occurrence of rash in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix with an associated reaction of rash (The patient received 1st dose of shingrix in May 2022. Refer case US2022AMR125990.).   In July 2022, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced rash. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the rash was not recovered/not resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.     Linked case(s) involving the same patient:  US2022125565, US2022AMR125990   Additional Information: GSK Receipt Date: 30-AUG-2022 Reporter's Comments: The reporter stated that a Patient developed a rash after 2nd dose also.  The reporter gave consent to follow up.; Sender's Comments:  US-GSK-US2022125565:Same reporter - FU1
14 days after last dose, routine blood work was performed and showed elvated ALT's and slightly low platelet count. All other reviewed numbers were normal. No previous lab work had shown any abnormal numbers.
PATIENT CALLED ON 10/21/18 @ 11:30AM AND SAID THAT SHE HAD THE FOLLOWING REACTIONS: CHILLS, DIZZINESS, FATIGUE, FEVER, HEADACHE, MALAISE, MUSCLE ACHES AND UNABLE TO MOVE AND COULDNT EVEN GET HERSELF TO GO USE THE BATHROOM. AS OF 10/21/18 SHE FEELS A LITTLE BETTER.
Fully vaccinated patient positive COVID test on 09/04/21 in ED, 24 hour stay and discharged with dexamethasone no O2 needs.  Patient fell on 09/06/21 and was admitted inpatient.  Some hypoxia (87%), cough, shortness of breath.  Dyspnea continued to worsen, starting having runs of SVT.  Required Bipap for increased respiratory needs.  Patient requested to move to hospice care and agressive therapy was discontinued per his request.  Patient died on 09/14/21.
Patient is a very lovely 33 year-old female who presented to the ED at hospital on 12/8/21 with complaints of a cough and chest pressure with shortness of breath for about 3 or four days prior to arrival. She has received her 1st COVID-19 vaccination but was not due for her 2nd until this month. Upon arrival to the ED she presented with stable vitals. Her CBC and CMP were unremarkable.  Her d-dimer was 2359.  A UA was consistent with a UTI but she had no GU complaints and the UA was not sent for a reflex culture.  Her rapid COVID-19 was positive.  Her CXR was normal and a CTA of the chest revealed a small left lower lobe pulmonary embolism.  In the ED was started on a heparin gtt.  She was given a dose of cephalexin x 1 and a dose of ketorolac for discomfort in her chest.  She was subsequently admitted to the PCU for further evaluation and management.
Headache and fatigue beginning approximately 8pm after 12:15pm injection.  Headache intensified by 18 hour mark; 800 mg of ibuprofen provided moderate relief from headache.  Headache persists to 41 hour mark (at time of this report).
Patient came into clinic complaining of right sided facial weakness that started on 10/13/21.
Information has been received from a physician concerning a pt who at age one year, was vaccinated once SC with a 0.5mL dose of varicella virus vaccine live and subsequently he developed leukopenia. The physician reported that the pt's mother refused to have his younger sibling vaccinated for that reason. The physician reported that when he did bloodwork on the unvaccinated child, that child had leukopenia. The physician reported that he thinks something genetic caused this, and that varicella virus vaccine live was not to blame in the case of the older child. There was no product quality complaint reported. The pt sought unspecified medical attention. Additional information has been requested.
After receiving the injection the patient temporarily passed out while in the chair. The patient regained consciousness and was able to walk to the waiting room and have a seat. The patient was given a cold pack and placed on the back of the neck and face to help with feeling warm.
Headache, Sedation, Fever, CHILLS AND SORE THROAT Narrative:  Other Relevant History:
generally not feeling well; a low grade fever; chills; freezing; couldn't get warm; tired and run down; sleepy; This is a spontaneous report from a contactable nurse (patient). A 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number EK5730), via an unspecified route of administration on 16Dec2020 08:40 AM at right deltoid, at single dose for covid-19 immunization. Medical history included sleep disorder. Concomitant medication included alprazolam prn (as needed) for sleep, HCTZ; losartan; metoprolol; montelukast sodium (SINGULAIR), levocetirizine dihydrochloride (XYZAL). On 18Dec2020 the patient had temperature of 98.8 which is low grade fever for her because she runs low. On 18Dec2020, she experienced a low grade fever, chills and was freezing. On 18Dec2020 she had chills and couldn't get warm. She had three layers on and a heating vest. It passed and she was doing fine. Those symptoms passed, but reappeared on 26Dec2020, last Saturday. Since then, she mentioned generally not feeling well, in addition to being freezing cold and experiencing chills every day. She had been monitoring her temperatures, and had no fever. Since 26Dec2020, she had chills, couldn't get warm, and no fever. She was tired and run down. She was sleepy and usually she was very energetic. The patient asked if have heard of such experience in other people. Seriousness Criteria was reported as it was not disabling, but annoying. It was unusual. She had on a thermal shirt that she would wear for skiing and that is not normal. Then on the 26Dec2020 the chills started back again. She felt kind of tired. She didn't feel sick, but not up to snuff. No AE required emergency room/physician office. The outcome of the event fever was recovered on 19Dec2020. The outcome of the events freezing; sleepy; tired and run down was unknown. The outcome of the other events was not recovered. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.
Information has been received from a healthcare professional referring to an unspecified number of patients of unknown age and gender. Information about medical history, concurrent condition and concomitant medications was not reported. On unknown dates the patients were vaccinated with RECOMBIVAX HB lot # K010535 with expiration date 27-AUG-2016; strength, dosage, frequency and route unspecified), which were post temperature excursion No adverse effects were noted by any patients. This is one of several reports received from the same reporter. Additional information has been requested.
On 2/17/12 at 13:05 pt received Tdap, w/in 30 min. pt reports HA. On 2/18/12 at 2 am pt woke w/ difficulty breathing: shaky feeling, noted itchy on neck/ears. At 8 AM noted difficulty breathing - assessed B/P 157/90, HR 130's decreased O2 85% paramedics called noted wheezing pt give - Albuterol and taken to ED breathing improved. On 2/20/12 pt states feeling dizzy & weak, follow up on 2/21/12 pt improved. Pt can be reached for more details - OK to leave message.
I started getting Tinnitus symptoms in my right ear in 01/2022. I went to the doctor and had hearing tests and an MRI. Both came back normal. I am not on any treatment right now but I am still experiencing it only in my right ear.
Patient was vaccinated on 3/31/21.  Noted to be positive for Covid on 4/19/21 and passed away on 5/8/21. Per the lab report, this is the information for the ordering provider:     He had an emergency contact but no number. Phone number for patient is no longer operational.
Injection site infection. Diagnosed by emergency department physician as cellulitis. Treatment for cellulitis was clindamycin 150 mg 2 capsule every 8 hours for 10 days.
Saturday August 5, symptoms "knots behind ears, headache, then on 8/8/06 severe headaches, 8/7/06 increased temperature, weakness, severe headaches. States "I have lost ten pounds". Placed on Prednisone, Claritin and Rhineacort. Saw MD 8/7/06 also treated at ER.
A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pain in the shoulder after the injection/arthralgia, now it's radiating, it's shifting from the shoulder to the neck/radiating pain. The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced the event(s) pain in the shoulder after the injection, now it's radiating, it's shifting from the shoulder to the neck. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported.  The outcome of event(s), pain in the shoulder after the injection, now it's radiating, it's shifting from the shoulder to the neck was unknown.
anxiety; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A 23 year-old female patient received bnt162b2 (BNT162B2), administration date 19Mar2021 (Lot number: EN6207) at the age of 23 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANXIETY (non-serious) with onset 19Mar2021, outcome "recovered" (19Mar2021), described as "anxiety". Therapeutic measures were taken as a result of anxiety. Additional information: During her 15-minute waiting period after the injection on 19Mar2021, the patient began to experience anxiety. She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. Mood and Affect: Mood is anxious. Affect is flat. Treatment included: water, snacks and blanket Follow up response to treatment: excellent. Patient discharge: Stable to go home and follow up with PCP.  No follow-up attempts are possible. No further information is expected.
After receiving the immunization, later that day had numbness/tingling in hands and feet. The next day also began to have pins/needles all over my body. It has not gone away. Also got a bad backache, lower back the day of the vaccine.
After first shot my back pain was very severe. Could not bend over or twist or lift anything. Gradually got better over a week. After the second shot the back pain flared up again so much so I could not go into work, had to get a professional massage to be able to even move. After 3 weeks from second shot, my lower back paid still plagues me and limits my ability to lift things over 5 pounds.
Blood in urine, vertigo, pins and needles on legs. Blood in urine visible on urine for 2 days and no longer visible but still on microscopic test. Vertigo stopped lasted for 5 days. Pins and needles on legs still present on day 10 after vaccination
Headache; Aching muscle at injection site; This case was reported by a consumer and described the occurrence of headache in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th September 2019, the patient received the 1st dose of Shingrix. In September 2019, less than a week after receiving Shingrix, the patient experienced headache and injection site muscle pain. On an unknown date, the outcome of the headache and injection site muscle pain were not recovered/not resolved.   It was unknown if the reporter considered the headache and injection site muscle pain to be related to Shingrix.  Additional details were provided as follows: The patient reported that, after vaccination with dose of Shingrix, experienced headache and muscle pain at the injection site. The reporter wanted to know how long does side effects would last.
Woke up after a bad night with cold sweats and muscle aches. No fever or other symptoms. It is near 5:00 pm, not much of a change.
client came to heath department with compliant of left arm hurting and not able to raise left arm up more than a couple of inches. client taking ibuprofen and putting warm compact on arm.
Immediately post vaccination pt reported feeling dizzy. Pt assisted to the floor to lay down safely with legs elevated, pt was diaphoretic. Pt lost consciousness for about 5 seconds. Pt was AXoX3 once recovered. ice packs and water provided. Pt reported feeling better and was assisted to sit down position at which time they stated they felt good. Pt assisted to chair and was escorted to observation at 2:42 pm with steady gate and AXOX3 for an additional 30 min observation.  Pt reported having similar reaction when blood was drawn. At 3:14 pm patient left site reporting symptoms resolved. Pt educated on signs and symptoms to seek medical attention for and pt verbalized understanding.
pt described tachycardia, requiring longer recovery period of heartrate after exercise (about 6 hours) resting heartrate 20 BPM more than normal  all data from patient's watch